All News

Regulatory & Standards

Learning From Experience: Navigating Cell & Gene Therapy Development Challenges with Productive CDMO Partnerships
9 May 2024
Learning From Experience: Navigating Cell & Gene Therapy Development Challenges with Productive CDMO Partnerships
In this interview, Andy Lewin,
Decentralized Manufacturing: Delivering on the Promise of Cell and Gene Therapy
27 February 2024
Decentralized Manufacturing: Delivering on the Promise of Cell and Gene Therapy
Manufacturing capacity, complexity and cost
European Commission Grants Approval for CASGEVY™ for Treatment of Sickle Cell Disease and Beta-Thalassemia
13 February 2024
European Commission Grants Approval for CASGEVY™ for Treatment of Sickle Cell Disease and Beta-Thalassemia
The European Commission has granted
Advanced Therapies Week 2024 Opening Plenary: Striving for a Future of Development Whilst Celebrating the Past
8 February 2024
Advanced Therapies Week 2024 Opening Plenary: Striving for a Future of Development Whilst Celebrating the Past
Advanced Therapies Week 2024's Opening
POPULAR NEWS ITEMS
Image
14 May 2024

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing

Image
8 April 2024

Women in Advanced Therapies Global 2024, Virtual Event

Image
25 March 2024

RNA Connect 2025, South Carolina

Advanced Therapies Week 2024: Navigating Innovation, Patient-Centricity, and the Regulatory Landscape in Cell and Gene Therapy
7 February 2024
Advanced Therapies Week 2024: Navigating Innovation, Patient-Centricity, and the Regulatory Landscape in Cell and Gene Therapy
In summary, the Superplenary at
The Future of Cell and Gene Therapy Manufacturing, Development, and Commercialization – Insights from Advanced Therapies Week 2024
29 January 2024
The Future of Cell and Gene Therapy Manufacturing, Development, and Commercialization – Insights from Advanced Therapies Week 2024
In this interview, Matthew Hewitt,
3P Innovation Marks Significant Milestone with Delivery of First Aseptic GMP Cryovial Filling Platform
3 January 2024
3P Innovation Marks Significant Milestone with Delivery of First Aseptic GMP Cryovial Filling Platform
3P Innovation delivers its first
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
29 November 2023
FDA Investigating ‘Serious Risk’ of Secondary Malignancy Linked to BCMA- or CD19-Directed CAR-T Immunotherapies
FDA investigates T cell malignancy
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing

Image

Women in Advanced Therapies Global 2024, Virtual Event

Image

RNA Connect 2025, South Carolina